Some have reported insomnia and nightmares when starting a GLP-1 but there is no clear causation
Advancing genetic, biomarker- and neuroimaging guidance will help treatments to become more precise, indicating the right time in the disease course for the right patient, from preclinical asymptomatic to early prodromal and dementia stages
When you're evaluating a medication that can control type 2 diabetes and potentially reverse insulin resistance, or that can help you lose up to 20% of your body weight, enduring a temporary, mild constipation isn't a bad idea
Common questions about GHK-Cu What is GHK-Cu and what does it do
Cagrilintide + retatrutide swaps semaglutide for retatrutide, which already hits three receptors (GLP-1, GIP, glucagon)